Balance Sheet Data
Viracta Therapeutics, Inc. (VIRX)
$0.489
-0.01 (-1.21%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 13.70 | 29.13 | 47.09 | 103.55 | 91.04 | 1,432.20 | 6,305.04 | 27,757.07 | 122,196.65 | 537,953.80 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.39 | 0.79 | 1.56 | 2.90 | 2.54 | 52.87 | 232.74 | 1,024.61 | 4,510.69 | 19,857.70 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | - | - | -0.05 | -4.25 | -0.04 | -29.10 | -128.11 | -563.97 | -2,482.79 | -10,930.12 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.